John P. Schmid
Director · 9 filings · Latest: Aug 10, 2026
ANAPTYSBIO, INC
BlossomHill Therapeutics, Inc.
Design Therapeutics, Inc.
First Tracks Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BLSM | John P. Schmid | Director | Aug 10, 2026 | Purchase | $16.00 | 6,000 | $96.0K | 6,000 | |
TRAX | John P. Schmid | Director | Jun 15, 2026 | Option Exercise | $0.00 | 6,030 | — | 37,652 | |
ANAB | John P. Schmid | Director | Jun 15, 2026 | Option Exercise | $0.00 | 6,030 | — | 37,652 | |
ANAB | John P. Schmid | Director | Mar 30, 2026 | Sale | $56.11 | 20,645 | $1.2M | 31,622 | |
ANAB | JOHN SCHMID | — | Mar 30, 2026 | Proposed Sale | $56.11 | 20,645 | $1.2M | — |